Description

3-(2,5-Dimethyl-7-Oxo-3-Phenyl-4,7-Dihydro-Pyrazolo[1,5-A]Pyrimidin-6-Yl)-Propionic Acid is a high-purity, advanced pharmaceutical intermediate characterized by its unique pyrazolopyrimidine core structure. This compound is critical for the synthesis of novel active pharmaceutical ingredients (APIs) targeting specific therapeutic pathways. It is primarily required by pharmaceutical R&D laboratories and fine chemical manufacturers engaged in developing next-generation small molecule drugs.

Application

• Pharmaceutical Intermediate: Key building block in the synthesis of novel drug candidates, particularly in oncology and anti-inflammatory research.
• Chemical Synthesis: Serves as a versatile precursor for creating complex heterocyclic compounds in medicinal chemistry.
• Research & Development: Used in academic and industrial R&D settings for structure-activity relationship (SAR) studies and lead optimization.
• Active Pharmaceutical Ingredient (API) Development: Integral component in the development pathway for new APIs requiring a functionalized pyrazolopyrimidine scaffold.
• Biochemical Research: Potential use as a tool compound or inhibitor in biochemical assays to study enzyme mechanisms.
• Custom Synthesis: Employed by contract research and manufacturing organizations (CRMOs) for client-specific molecule production.

Basic Information

Product Name	3-(2,5-Dimethyl-7-Oxo-3-Phenyl-4,7-Dihydro-Pyrazolo[1,5-A]Pyrimidin-6-Yl)-Propionic Acid
CAS No.	878417-25-5
Molecular Formula	C18H17N3O3
Molecular Weight	323.35 g/mol
Synonyms	3-(2,5-Dimethyl-7-oxo-3-phenyl-4,7-dihydropyrazolo[1,5-a]pyrimidin-6-yl)propanoic acid; 6-(2-Carboxyethyl)-2,5-dimethyl-3-phenyl-4,7-dihydropyrazolo[1,5-a]pyrimidin-7-one; Propanoic acid, 3-(2,5-dimethyl-7-oxo-3-phenyl-4,7-dihydro-pyrazolo[1,5-a]pyrimidin-6-yl)-; 878417-25-5; Pyrazolo[1,5-a]pyrimidine-6-propanoic acid derivative
EINECS	Contact for details

Quality Control

Our 3-(2,5-Dimethyl-7-Oxo-3-Phenyl-4,7-Dihydro-Pyrazolo[1,5-A]Pyrimidin-6-Yl)-Propionic Acid is manufactured under strict quality management systems. Each batch undergoes rigorous analytical testing, including HPLC for purity and NMR/IR for structural confirmation, to ensure it meets the high standards required for pharmaceutical R&D. A comprehensive Certificate of Analysis (COA) detailing identity, purity, and impurity profiles is provided with every shipment.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at controlled room temperature (15-25°C). Keep the container tightly sealed to protect from moisture.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (IR)	Conforms to structure
Identification (HPLC)	Retention time matches reference
Purity (HPLC)	≥ 98.0%
Water Content (KF)	≤ 0.5%
Residue on Ignition	≤ 0.1%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.